Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
{{output}}
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health priority. Small-molecule antivirals like remdesivir (RDV) and biologics such as human monoclonal antibodies (mAbs) have demonstrated therapeutic efficacy against SARS-... ...
